Parenteral formulations of...

Details Parenteral formulations of... Parenteral formulations of...

A - Human Necessities

61

K

A61K 47/48 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2454913

Disclosed are formulations and compositions comprising, and process for preparing, improved parenteral dosageforms of 1-(5-tert-buryl-2-p-tolyl-2H- pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea. Also disclosed are methods of treating cytokine mediated diseases using such formulations and compositions.

L'invention concerne des formulations et des compositions comprenant des formes de dosage parentérales améliorées de 1-(5-tert-buryl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphtalen-1-yl]-urée et leur procédé de préparation. L'invention concerne également des méthodes permettant de traiter des maladies induites par la cytokine à l'aide desdites formulations et compositions.

Affiliated with

Also associated with

Rating

Parenteral formulations of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Parenteral formulations of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parenteral formulations of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1479086